A risk-based treatment strategy for non-rhabdomyosarcoma soft-tissue sarcomas in patients younger than 30 years (ARST0332): a Children's Oncology Group prospective study
Sheri L. Spunt(Stanford Medicine), Lynn Million(Stanford University), Yueh-Yun Chi(University of Florida), James R. Anderson(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jing Tian(University of Florida), Emily Hibbitts(University of Florida), Cheryl M. Coffin(Vanderbilt University), M. Beth McCarville(St. Jude Children's Research Hospital), R. Lor Randall(University of California, Davis), David M. Parham(Children's Hospital of Los Angeles), Jennifer O. Black(Children's Hospital Colorado), Simon C. Kao(University of Iowa), Andrea Hayes‐Jordan(University of North Carolina at Chapel Hill), Suzanne L. Wolden(Memorial Sloan Kettering Cancer Center), Fran Laurie, Roseanne Speights(St. Jude Children's Research Hospital), Ellen Kawashima(Children's Oncology Group), Stephen X. Skapek(The University of Texas Southwestern Medical Center), William H. Meyer(University of Oklahoma Health Sciences Center), Alberto S. Pappo(St. Jude Children's Research Hospital), Douglas S. Hawkins(Seattle Children's Hospital)
Cited by 172Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis